ABSTRACT

Background
In patients with ST-segment elevation myocardial infarction (STEMI), the importance of a well-balanced inflammatory reaction has been recognized for years. Monocytes play essential roles in regulating inflammation. Hence, we investigated the association between inflammatory characteristics of monocytes and myocardial injury and functional outcome in patients with STEMI.
Methods
Using flow cytometry, the levels of classical (CD14 ++ CD62L + ) and nonclassical (CD14 + CD62L − ) monocytes were analysed in peripheral blood in 58 patients with STEMI at a median of 5 days (4-6 days) after primary percutaneous coronary intervention. In addition, the monocytic expression of several surface molecules and formation of monocyte-platelet complexes were measured. All patients underwent cardiovascular magnetic resonance imaging at baseline and 4-month follow-up.
INTRODUCTION
After acute myocardial infarction, immune cells play a central role in protecting viable myocardium from ischemic damage and promoting repair of the infarcted tissue. On the other hand, patients with a proinflammatory immune response during the acute phase of ischemia show impaired recovery of the left ventricular (LV) function,(1;2) indicating that inflammation, if poorly controlled, may deleteriously affect the healing process.
Monocytes play essential roles in regulating postinfarct inflammation. It has been appreciated that monocytes are a heterogeneous population of cells that can be divided into 2 major subsets based on their phenotype.(3) Classical monocytes have proinflammatory properties and enhance postinfarct inflammation, whereas nonclassical monocytes attenuate inflammation and promote tissue repair.(4) Recently, Tsujioka et al. (5) measured the levels of the classical and nonclassical monocytes in 36 patients with ST-segment elevation myocardial infarction (STEMI) and found an association between higher levels of proinflammatory classical monocytes and impaired recovery of LV function. Furthermore, multiple studies indicate that the inflammatory properties of monocytes are regulated by adhesion molecules such as macrophage (Mac) 1, very late antigen (VLA) 4, intercellular adhesion molecule (ICAM) 1, and the formation of monocyte-platelet complexes. (6) (7) (8) (9) Using highly accurate and quantitative cardiovascular magnetic resonance (CMR) imaging techniques, this study investigates the association between inflammatory characteristics of circulating monocytes, myocardial injury, and functional outcome in a large cohort of patients with STEMI.
METHODS
Patient selection and study procedures
This hypothesis-generating study was part of the HEBE study, of which the design and main results have been reported previously.(10;11) In summary, the HEBE study was a multicentre, randomized, open trial investigating the effect of intracoronary infusion of bone marrow mononuclear cells (BMMC) and peripheral blood mononuclear cells (PBMCs) after STEMI. A total of 200 patients with a first STEMI treated with primary percutaneous coronary intervention (PCI) were included in the HEBE trial. Patients underwent baseline CMR at least 2 days after primary PCI. Subsequently, patients were randomly assigned to BMMC therapy, PBMC therapy, or standard therapy. At 4-month follow-up, CMR was repeated. The trial did not show any effect of intracoronary delivery of BMMCs or PBMCs as compared with standard therapy on regional and global systolic LV function, LV volumes, or infarct size, as assessed by CMR.(11) For the current substudy, patients randomized to the PBMC group were selected (n=66). The monocyte counts were determined at the local cell processing laboratory. After preparation of the mononuclear cell suspension using density gradient centrifugation,(11;12) a small portion of the cell suspension was immediately sent to the central cell processing laboratory at Sanquin Research (Amsterdam, The Netherlands) for further characterization of the monocytes. The study was conducted in accordance with the Declaration of Helsinki, and the study protocol was approved by institutional review boards of the participating institutes. All patients gave informed consent.
Characterization of monocytes by flow cytometry
Antigen expression was measured using flow cytometry on a fluorescence-activated cell scanner (CANTO, BD Biosciences, San Jose, CA), and data analysis was performed with FACSDiva software (BD Biosciences, San Jose, CA) at Sanquin Research within 24 hours after cell isolation. Monocytes were identified as CD14 + cells. The classical monocytes were defined as CD14 ++ CD62L + cells, and the nonclassical monocytes, as Figure S1A) . (3) The percentage of classical and nonclassical monocytes within the monocyte population, as measured by flow cytometry, and the absolute number of monocytes measured before cell isolation were used to calculate the absolute blood levels of classical and nonclassical monocytes. In addition, the expression of Mac-1 (CD11b), VLA-4 (CD49d), and ICAM-1 (CD54) was measured as the mean fluorescence intensity on CD14 + cells. The formation of monocyte-platelet complexes was quantified by measuring the mean coexpression of the constitutive platelet marker glycoprotein 1b (CD42b) on CD14 + cells (Supplementary Figure S1B) .
Monoclonal antibodies included anti-CD14 (PerCP, MΦP9; BD Biosciences, San Jose, CA), anti-CD62L (allophycocyanin, clone SK11; BD Biosciences), anti-CD11b (allophycocyanin, clone D12; BD Biosciences), anti-CD49d (allophycocyanin, clone 7.2R; R&D Systems, Abingdon, United Kingdom), anti-CD54 (allophycocyanin, clone HA58; BD Biosciences), and anti-CD42b (phycoerythrin, clone AN51; Dako Cambridgeshire, United Kingdom).
Cardiovascular magnetic resonance protocol
Patients were studied on a clinical 1.5-or 3.0-T clinical scanner using a phased array cardiac receiver coil. Cardiovascular magnetic resonance acquisition and analyses involved a standardized protocol published previously. (11) In short, contiguous short-axis slices were acquired every 10 mm, covering the whole left ventricle. First-pass perfusion was performed during administration of a gadolinium-based contrast agent (Dotarem; Guerbet, Gorichem, The Netherlands; 0.1 mmol/kg) at a rate of 3.0 mL/s using a dynamic single-shot saturation recovery gradient echo pulse sequence. Three short-axis slices were obtained per heartbeat, every 10 mm, covering the infarcted area of the left ventricle. Immediately after first-pass perfusion imaging, an additional 0.1 mmol/kg of contrast agent was administered (cumulative dose 0.2 mmol/kg). Late gadoliniumenhanced (LGE) images were acquired 10 to 15 minutes after the second contrast administration using a 2-dimensional segmented inversion recovery gradient echo pulse sequence with slice position identical to the cine images.
Cardiovascular magnetic resonance data analysis and definitions
All CMR data were analysed in 1 core laboratory, blinded for data regarding numbers of monocytes, using dedicated software (Mass; Medis, Leiden, The Netherlands). Cine, first-pass perfusion, and LGE images acquired during the same imaging session were matched by using slice position. Left ventricular volumes and mass were measured on the cine images and indexed for body surface area. For analysis of the regional LV myocardial function, each short-axis slice was divided in 12 equiangular segments. Myocardial segments were considered dysfunctional if segmental wall thickening was <3 mm. 13 The measurement of infarct size, extent of transmurality, and the presence and extent of microvascular obstruction on LGE images were performed as previously described. (11;13) First-pass perfusion imaging was analysed using the short-axis slice through the infarct core. In this slice, the myocardial segment with the highest LGE transmurality and lowest upslope during first-pass perfusion was defined as the infarct core. The perfusion of the infarct core was quantified by the relative upslope during first-pass perfusion.
Statistical analysis
Data with normal distribution are expressed as mean ± SD, and data with non-normal distribution are given as median value (25th-75th percentile). Categorical data are presented as number (percentage). To test for differences between groups, 1-way analysis of variance or Student t test was used for data with a normal distribution, and the Kruskal-Wallis test was used for data with a non-normal distribution. The χ 2 test was used for testing associations between categorical data. Linear nonparametric correlation was calculated using the Spearman correlation. Furthermore, we assessed the association between baseline extent of transmural infarction and the level of classical or nonclassical monocytes for segmental wall thickening at follow-up. Because wall thickening in different segments within 1 patient is strongly related, outcomes were analysed using multilevel linear analysis with 3 levels: segments within slices and slices within patients. (11) 
RESULTS
Patient characteristics
Of the 200 patients included in the HEBE trial, 66 patients were assigned to the PBMC group. Paired cine CMR images and valid flow cytometry measurements were available in 58 patients of the PBMC group. Paired first-pass perfusion and LGE images were available for 53 patients. The baseline characteristics of the study population are shown in Table 1 . The mean age of the study population was 56 ± 10 years, 83% were male, and the median time from onset of symptoms to reperfusion was 2.9 hours (2.2-4.8 hours). Mean baseline LV ejection fraction was 42% ± 9%, and mean infarct size was 18% ± 9% of the left ventricle. Values are expressed as number (%), mean ± SD, or median (25th-75th percentile).
High blood levels of classical monocytes are related to enhanced myocardial injury and impaired LV function at baseline and at follow-up
Flow cytometric analysis was performed at a median of 5 days (4-6 days) after primary PCI. The mean circulating number of monocytes was 719 ± 230*10 6 /L, which comprised for approximately 90% of classical monocytes (Table 1) . Next, we grouped the patients into tertiles based on the absolute number of circulating classical monocytes or the absolute number of nonclassical monocytes. Patient characteristics were comparable across tertiles of classical and nonclassical monocytes (Supplementary Table SI) . At baseline, patients with high levels of circulating classical monocytes had impaired LV function, larger infarct size, and, often, presence of microvascular obstruction ( Figure 1A ). In addition, the extent of transmural infarction and the extent of microvascular obstruction were increased in patients with high levels of circulating classical monocytes, and perfusion of the infarct core was reduced (Table 2) . Interestingly, we observed opposite trends among tertiles of nonclassical monocytes, although not significant ( Figure 1B and Table  2 ). At 4-month follow-up, patients with high levels of classical monocytes had worse functional outcome. These patients displayed larger infarct size, concomitant with an impaired global and regional LV function (Table 2) . Again, opposite trends were found for the nonclassical monocytes (Table 2) .
High blood levels of classical monocytes are associated with impaired recovery of the regional myocardial function independent of transmural extent of infarction
To gain more insight in the association between levels of circulating monocyte subsets and LV functional outcome, we extended our analyses to the regional recovery of systolic LV function of segments that were dysfunctional at baseline. Overall, wall thickening in dysfunctional segments improved between baseline and follow-up. The improvement in wall thickening was reduced in patients with high levels of circulating classical monocytes ( Figure 2A ). In contrast, we observed a trend pointing at enhanced recovery of dysfunctional segments in patients with high levels of nonclassical monocytes ( Figure 2B ). As expected, segmental wall thickening at 4-month follow-up was closely related to the extent of transmural infarction at baseline ( Figure 3A) . Therefore, we further evaluated the relation between the level of circulating monocytes and wall thickening, stratified by the transmural extent of infarction. In patients with high levels of classical monocytes, wall thickening at 4 months was lower in all different infarct zones (ranging from 1% to >75% transmural extent of infarction) even in segments without infarction ( Figure 3B ). Interestingly, opposite trends were found for the nonclassical monocytes ( Figure 3C ). Values are expressed as mean ± SD, or median (25th-75th percentile). LV denotes left ventricular;
LGE, late gadolinium-enhanced; MVO, microvascular obstruction. *P-value for trend. †
Spearman correlation
P-value.
Expression of Mac-1 on monocytes and formation of monocyteplatelet complexes are related to myocardial injury and LV function at baseline and at follow-up
We also evaluated the monocytic expression of Mac-1, VLA-4, ICAM-1 and formation of monocyte-platelet complexes (Table 3 ). There was a significant but moderate association between a higher monocytic surface density of Mac-1 and extensive myocardial injury, as demonstrated by increased extent of transmural infarction, presence of microvascular obstruction, and lower perfusion in the infarct core. Moreover, up-regulation of Mac-1 was related to a lower LV function at baseline and 4-month follow-up. Furthermore, the formation of monocyte-platelet complexes was associated with larger infarct size, increased extent of transmural infarction, increased extent of microvascular obstruction, Figure 2 The association between circulating levels of classical and nonclassical monocytes and recovery of regional myocardial function. The change in wall thickening in dysfunctional segments from baseline to 4 months is depicted for tertiles of classical monocytes (A) and nonclassical monocytes (B). Data are presented as mean ± SD. P-values for the change between baseline and follow-up within each tertile were calculated with paired Student t test. For the change in wall thickening from baseline to 4-month follow-up, P-values were determined by the Spearman correlation test. Base denotes baseline; FU, follow-up.
and decreased perfusion in the infarct core, concomitant with a lower LV ejection fraction at baseline and follow-up. 
DISCUSSION
The results of the present study show a significant association between high blood levels of classical monocytes and extensive myocardial injury in patients with STEMI, as demonstrated by large infarct size, increased extent of transmural infarction, and presence of microvascular obstruction at baseline. At follow-up, the regional systolic LV function was impaired in patients with high levels of classical monocytes, independent of the transmural extent of infarction. Intriguingly, we observed opposite trends for nonclassical monocytes. Finally, up-regulation of Mac-1 by blood monocytes and increased formation of monocyte-platelet complexes was associated with enhanced myocardial injury at baseline and impaired LV function at follow-up. Appropriate infarct healing requires a well-orchestrated inflammatory reaction that balances debris removal and tissue repair. Monocytes play an important role in coordinating this process. Nahrendorf et al.(4) have demonstrated in a murine model of myocardial infarction that classical monocytes promote inflammation and removal of dead cells and debris, whereas nonclassical monocytes attenuate inflammation and emphasize repair of the tissue. A previous clinical study by Tsujioka et al.(5) showed that a high level of classical monocytes after primary PCI was negatively associated with recovery of the global LV function, suggesting that enhanced mobilization of classical monocytes may adversely affect the recovery process.
In accordance with the clinical study of Tsujioka et al., (5) we demonstrated an association between high levels of classical monocytes and extensive myocardial injury at baseline together with a poor regional and global LV function at follow-up. Classical and nonclassical monocytes were distinguished by the differential expression of L-selectin on monocytes, (14) an adhesion molecule that mediates monocyte rolling on activated endothelium and is expressed by the classical monocytes (and not the nonclassical monocytes).(3) Importantly, we also observed a negative association between the level of circulating classical monocytes and segmental wall thickening at follow-up, independent of the degree of infarct transmurality. Even wall thickening in segments outside the infarct zone was lower in patients with high blood levels of classical monocytes. Intriguingly, we found an opposite trend for the level of circulating nonclassical monocytes with regard to the regional systolic LV function at follow-up, suggesting that nonclassical monocytes may be beneficially involved in the healing process after STEMI. The reason that we did not find statistical significant associations with regard to the nonclassical monocytes might be because of the low number of patients that we included and thereby, a lack of power of this study.
Microvascular obstruction after primary PCI is an important determinant of recovery of global and regional LV function after acute myocardial infarction.(13;15) Inflammation, coagulation, and microvascular plugging are all hallmarks of microvascular obstruction. (16) Here, we found the monocytic expression of Mac-1 to be moderately associated with parameters of microvascular obstruction. Macrophage 1 is an adhesion molecule that interacts with ICAM-1, which is expressed on activated endothelial cells, (17) and facilitates monocyte adhesion.(14) Furthermore, Mac-1/ICAM-1 interaction triggers inflammatory signalling pathways in the monocyte, leading to the transcription of the inflammatory cytokines interleukin-1β and tumor necrosis factor α and tissue factor, a protein involved in the initiation of blood coagulation cascades.(8;9) Furthermore, we observed a moderate association between increased formation of monocyte-platelet complexes and myocardial injury. Activated platelets interact with monocytes via P-selectin ligand and Mac-1,(7) and this complex formation has been shown to augment Mac-1-triggered signalling pathways, promoting inflammation.(6;7) These data reveal a link between the inflammatory status of monocytes and microvascular obstruction.
Overall, this study shows an important association between a proinflammatory monocyte response and impaired functional LV recovery in patients with STEMI. Future studies are required to investigate the biologic nature of this association and therapeutic implications.
Study limitations
There are several limitations to the present study. First, all patients but 1 received intracoronary cell therapy, which may have influenced infarct size and LV myocardial function at 4-month follow-up (but not baseline myocardial injury and LV myocardial function). However, the results of the HEBE study showed no effect of PBMC therapy on the recovery of the regional as well as the global myocardial function as compared with the control group at 4-month follow-up.(11) Second, our results can only identify associations rather than causal relationships, and findings should be interpreted cautiously, given the large numbers of analyses that were performed. Third, our sample size might be too small to detect small differences between monocyte concentrations and functional outcome. Fourth, studying monocyte numbers in peripheral blood may represent a limited view of monocyte traffic to the infarcted area. Fifth, the determination of the level of classical and nonclassical in blood and monocytic expression of surface molecules was performed only once (between 3 and 8 days after primary PCI). This may have influenced the association between levels of monocytes and outcome. In addition, expression of surface molecules and formation of monocyte-platelet complexes were measured on the total monocyte population only. Sixth, baseline CMR was not performed on a fixed time point. However, it is known from previous work that the extent of microvascular obstruction and infarct size is stable between 2 and 6 days after primary PCI. Values are expressed as number (%), mean ± SD, or median (25th-75th percentile). CHD denotes coronary heart disease; LAD, left anterior descending coronary artery. *P-value for trend. † Spearman correlation P-value.
